{
  "meta": {
    "title": "23_Gestational_Trophoblastic_Diseases",
    "url": "https://brainandscalpel.vercel.app/23-gestational-trophoblastic-diseases-a6fb5f83.html",
    "scrapedAt": "2025-11-30T12:29:54.040Z"
  },
  "questions": [
    {
      "text": "What is the chromosome number of a partial hydatidiform mole?",
      "choices": [
        {
          "id": 1,
          "text": "46 XX"
        },
        {
          "id": 2,
          "text": "45 XY"
        },
        {
          "id": 3,
          "text": "69 XY"
        },
        {
          "id": 4,
          "text": "69 XXY"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Partial</strong> hydatidiform mole has a <strong>69XXY or 69XYY karyotype</strong>.</p>\n<p><strong>Hydatiform</strong> <strong>mole</strong> belongs to the <strong>benign</strong> group of gestational trophoblastic diseases <strong>(GTD)</strong>. It is an <strong>abnormality</strong> in <strong>chorionic</strong> <strong>villi</strong> making them <strong>partly</strong> <strong>proliferative</strong> and <strong>degenerative</strong>, thereby resulting in the formation of multiple small cysts. Based on the portion of the chorionic villi involved, they could be <strong>complete</strong> (<strong>diffused</strong>) or <strong>partial (focal)</strong></p><hr><h3>Related Pearl: Complete vs. Partial Mole</h3><p>Hydatidiform mole is a <strong>benign</strong> abnormal condition of the placenta characterized by partial degenerative or proliferative changes of the <strong>chorionic villi</strong>. Though benign, it has malignant potential. It is commonly seen in pregnancies of extreme reproductive age groups - <strong>teenage</strong> and women <strong>above 35 years</strong> of age. A previous <strong>history of molar pregnancy</strong> is also a strong risk factor for recurrence of this condition.</p>\n<p>Molar pregnancy is of 2 types - complete mole and partial mole.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>Partial mole</strong></td>\n<td><strong>Complete mole</strong></td>\n</tr>\n<tr>\n<td><strong>Karyotype</strong></td>\n<td>69 XYY or 69 XXY</td>\n<td>46 XX or 46 XY</td>\n</tr>\n<tr>\n<td><strong>Diagnosis</strong></td>\n<td>Missed abortion</td>\n<td>Molar gestation</td>\n</tr>\n<tr>\n<td><strong>Uterus size</strong></td>\n<td>Small for date</td>\n<td>Large for date</td>\n</tr>\n<tr>\n<td><strong>Theca-lutein cysts</strong></td>\n<td>Rare</td>\n<td>25&ndash;30% of cases</td>\n</tr>\n<tr>\n<td><strong>Initial hCG levels</strong></td>\n<td>&lt;1 lakh mIU/ml</td>\n<td>&gt;1 lakh mIU/ml</td>\n</tr>\n<tr>\n<td><strong>Medical complications</strong></td>\n<td>Rare</td>\n<td>Uncommon</td>\n</tr>\n<tr>\n<td><strong>Rate of subsequent GTN</strong></td>\n<td>1&ndash;5%</td>\n<td>15&ndash;20%</td>\n</tr>\n<tr>\n<td><strong>Embryo-fetus</strong></td>\n<td>&nbsp;Often present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td><strong>Amnion, fetal erythrocytes</strong></td>\n<td>Often present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td><strong>Villous edema</strong></td>\n<td>&nbsp;Focal</td>\n<td>Widespread</td>\n</tr>\n<tr>\n<td><strong>Trophoblastic proliferation</strong></td>\n<td>Focal, slight to moderate</td>\n<td>Slight to severe</td>\n</tr>\n<tr>\n<td><strong>Trophoblast atypia</strong></td>\n<td>Mild</td>\n<td>Marked</td>\n</tr>\n<tr>\n<td><strong>p57KIP2 immunostaining</strong></td>\n<td>Positive</td>\n<td>Negative</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/abb92edd8fe94b1997c1f9c5bf1a559ex1280x2039.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7485",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is false regarding hydatidiform moles?",
      "choices": [
        {
          "id": 1,
          "text": "Complete moles show diffuse trophoblastic hyperplasia"
        },
        {
          "id": 2,
          "text": "Fetal tissue is seen in partial mole"
        },
        {
          "id": 3,
          "text": "Early USG is sensitive for partial moles"
        },
        {
          "id": 4,
          "text": "Complete moles have higher malignant potential"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Early ultrasonography is not highly sensitive in a patient with partial molar pregnancy. However, USG features like thickened, multicystic placenta along with fetal tissue or even a fetus may be seen.</p>\n<p>Hydatidiform mole or <strong>molar pregnancy</strong> is an abnormal condition of the <strong>placenta.</strong> It is characterized by <strong>trophoblastic proliferation</strong> and stromal edema. They are <strong>classified</strong> into <strong>complete</strong> and <strong>partial</strong> moles based on the&nbsp;absence or presence of <strong>embryonic elements</strong>.&nbsp;</p>\n<p><strong>Pathogenesis</strong> of complete and partial moles are as follows:&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c1116676e3ec4f57b71731e990d82b88x1280x1250.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6c3378717dfa45e4bfdc92c97d925c7bx1280x1020.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Complete vs. Partial Mole</h3><p>Hydatidiform mole is a <strong>benign</strong> abnormal condition of the placenta characterized by partial degenerative or proliferative changes of the <strong>chorionic villi</strong>. Though benign, it has malignant potential. It is commonly seen in pregnancies of extreme reproductive age groups - <strong>teenage</strong> and women <strong>above 35 years</strong> of age. A previous <strong>history of molar pregnancy</strong> is also a strong risk factor for recurrence of this condition.</p>\n<p>Molar pregnancy is of 2 types - complete mole and partial mole.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>Partial mole</strong></td>\n<td><strong>Complete mole</strong></td>\n</tr>\n<tr>\n<td><strong>Karyotype</strong></td>\n<td>69 XYY or 69 XXY</td>\n<td>46 XX or 46 XY</td>\n</tr>\n<tr>\n<td><strong>Diagnosis</strong></td>\n<td>Missed abortion</td>\n<td>Molar gestation</td>\n</tr>\n<tr>\n<td><strong>Uterus size</strong></td>\n<td>Small for date</td>\n<td>Large for date</td>\n</tr>\n<tr>\n<td><strong>Theca-lutein cysts</strong></td>\n<td>Rare</td>\n<td>25&ndash;30% of cases</td>\n</tr>\n<tr>\n<td><strong>Initial hCG levels</strong></td>\n<td>&lt;1 lakh mIU/ml</td>\n<td>&gt;1 lakh mIU/ml</td>\n</tr>\n<tr>\n<td><strong>Medical complications</strong></td>\n<td>Rare</td>\n<td>Uncommon</td>\n</tr>\n<tr>\n<td><strong>Rate of subsequent GTN</strong></td>\n<td>1&ndash;5%</td>\n<td>15&ndash;20%</td>\n</tr>\n<tr>\n<td><strong>Embryo-fetus</strong></td>\n<td>&nbsp;Often present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td><strong>Amnion, fetal erythrocytes</strong></td>\n<td>Often present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td><strong>Villous edema</strong></td>\n<td>&nbsp;Focal</td>\n<td>Widespread</td>\n</tr>\n<tr>\n<td><strong>Trophoblastic proliferation</strong></td>\n<td>Focal, slight to moderate</td>\n<td>Slight to severe</td>\n</tr>\n<tr>\n<td><strong>Trophoblast atypia</strong></td>\n<td>Mild</td>\n<td>Marked</td>\n</tr>\n<tr>\n<td><strong>p57KIP2 immunostaining</strong></td>\n<td>Positive</td>\n<td>Negative</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/abb92edd8fe94b1997c1f9c5bf1a559ex1280x2039.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1485",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not associated with the development of a hydatidiform mole?",
      "choices": [
        {
          "id": 1,
          "text": "Maternal age >40 years"
        },
        {
          "id": 2,
          "text": "Previous history of GTD"
        },
        {
          "id": 3,
          "text": "AB blood group"
        },
        {
          "id": 4,
          "text": "Vitamin C deficiency"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Vitamin A deficiency,<strong> not Vitamin C deficiency</strong>&nbsp;is a risk factor for hydatidiform mole.</p>\n<p><strong>Risk factors</strong> for <strong>hydatidiform mole</strong> are:</p>\n<ul>\n<li>Maternal age - pregnancy in teenage and women &gt;35 years</li>\n<li>Previous history of gestational trophoblastic disease</li>\n<li>Dietary deficiency - vitamin A deficiency, inadequate protein and animal fat intake</li>\n<li>AB blood group.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9840",
      "difficulty": "medium"
    },
    {
      "text": "A 20-year-old primigravida with bleeding PV was diagnosed to have a complete hydatidiform mole. Which of the following is not true in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Serum β-hCG levels are highly elevated"
        },
        {
          "id": 2,
          "text": "Urine pregnancy test is negative"
        },
        {
          "id": 3,
          "text": "Theca lutein cysts are rare"
        },
        {
          "id": 4,
          "text": "Serum free T4 levels normalise after uterine evacuation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Theca lutein cysts</strong> are <strong>rare</strong> in <strong>partial</strong> molar pregnancy, but may be seen in <strong>25-30%</strong> of patients with <strong>complete</strong> molar pregnancy.</p>\n<div class=\"page\" title=\"Page 418\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Serum <strong>&beta;-hCG</strong> levels are <strong>elevated</strong> more than expected for gestational age in a complete mole.</p>\n<p>The sensitivity of most hCG tests is set to the pregnancy hCG range. An excessive &beta;-hCG hormone causes an <strong>oversaturation</strong> of the <strong>test assay</strong> giving a<strong> false negative</strong> <strong>UPT</strong>.&nbsp;This is called the&nbsp;<strong>hook effect.</strong></p>\n<div class=\"page\" title=\"Page 418\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The <strong>thyrotropin-like effects</strong> of <strong>hCG</strong> frequently cause serum free-T4 levels to be elevated which <strong>normalize</strong> after uterine <strong>evacuation.</strong></p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9846",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant woman at 12 weeks of gestation presents with spotting PV, hyperemesis, and lower abdominal pain for the past 2 days. USG done is shown below. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Missed abortion"
        },
        {
          "id": 2,
          "text": "Complete mole"
        },
        {
          "id": 3,
          "text": "Partial mole"
        },
        {
          "id": 4,
          "text": "Choriocarcinoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario and USG showing <strong>snowstorm</strong> <strong>appearance</strong> is suggestive of a&nbsp;<strong>complete mole.</strong>&nbsp;</p>\n<p>The snowstorm appearance&nbsp;is due to an echogenic uterine mass that has numerous <strong>anechoic</strong> <strong>cystic</strong> <strong>spaces</strong>. Fetus and amniotic sac are absent.&nbsp;</p>\n<p><strong>Investigations</strong>&nbsp;for&nbsp;<strong>molar pregnancy </strong>are:</p>\n<ul>\n<li>USG - shows snowstorm appearance</li>\n<li>Serum&nbsp;&beta; hCG - elevated to &gt;2 MoM (multiples of median) for corresponding gestational age</li>\n<li>Histological examination of products of conception</li>\n</ul>\n<p><strong>Snowstorms in radiology</strong>:</p>\n<ul>\n<li>Complete hydatiform mole (ultrasound)</li>\n<li>Extracapsular breast implant rupture (ultrasound)</li>\n<li>Carcinoma thyroid - pulmonary metastases (chest X-ray).</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a92997b29d0e49918af4f5e8f1f3325d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9847",
      "difficulty": "easy"
    },
    {
      "text": "A primigravida at 12 weeks of gestation presented with complaints of the expulsion of grape-like vesicles PV for the past day. A diagnosis of molar pregnancy was made on USG examination. Incidentally, the following adnexal lesion was also noted. What is the lesion?",
      "choices": [
        {
          "id": 1,
          "text": "Mucinous cystadenoma"
        },
        {
          "id": 2,
          "text": "Multilocular endometrial cysts"
        },
        {
          "id": 3,
          "text": "Theca lutein cyst"
        },
        {
          "id": 4,
          "text": "Polycystic ovarian disease"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given USG image shows <strong>theca lutein cysts</strong> in the ovary. These cysts are usually&nbsp;seen in patients with&nbsp;<strong>complete</strong> molar pregnancies.&nbsp;They are usually <strong>bilateral</strong> and are also seen in multiple pregnancies.</p>\n<p>Theca lutein cysts result from the <strong>overstimulation</strong> of <strong>lutein elements</strong> by massive amounts of&nbsp;<strong>&beta;</strong> <strong>hCG</strong>. The cystic fluid is rich in chorionic gonadotropin, estrogen, and progesterone.&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5d4f3e74056e48269ad48bef0d0230f2.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1487",
      "difficulty": "easy"
    },
    {
      "text": "A patient who was treated for molar pregnancy came for follow-up after 4 months. Her USG revealed a large, twisted theca lutein cyst. How will you manage this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Untwisting of the cyst"
        },
        {
          "id": 2,
          "text": "Laparoscopic oophorectomy"
        },
        {
          "id": 3,
          "text": "Wait and watch"
        },
        {
          "id": 4,
          "text": "Transabdominal aspiration under USG guidance"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Untwisting of the cyst</strong> is the only management in an <strong>asymptomatic</strong> patient with a twisted theca lutein cyst.</p>\n<p>Laparoscopic <strong>oophorectomy</strong> is done only when there is associated extensive <strong>necrosis or hemorrhage</strong>.</p>\n<p>Theca-lutein cysts regress within 2 months after pregnancy evacuation, and hence <strong>expectant</strong> management is preferred in <strong>uncomplicated</strong> cases.&nbsp;If the cysts are <strong>symptomatic</strong>, they can be <strong>aspirated</strong> trans-abdominally under ultrasound guidance.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9841",
      "difficulty": "hard"
    },
    {
      "text": "A pregnant woman at 14 weeks of gestation complains of excessive vomiting and mild vaginal bleeding for 2 weeks. On examination, fundal height corresponds to 16 weeks and fetal heart sounds are absent. USG shows a snowstorm appearance and no fetus. What is the best step of management?",
      "choices": [
        {
          "id": 1,
          "text": "Chemotherapy"
        },
        {
          "id": 2,
          "text": "Hysterectomy"
        },
        {
          "id": 3,
          "text": "Suction and evacuation"
        },
        {
          "id": 4,
          "text": "Serum beta hCG"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of <strong>molar pregnancy </strong>which is managed by<strong> suction and evacuation,&nbsp;</strong>regardless of uterine size.</p>\n<p>If the <strong>cervix</strong> is <strong>unfavorable</strong>, slow dilatation is done with&nbsp;vaginal <strong>PGE1</strong>. Volume resuscitation with IV fluids and parenteral antibiotics can be given as supportive therapy. Blood transfusion is done if the patient is anaemic.</p>\n<p>Intraoperative sonography is recommended to help ensure that the uterine cavity has been emptied.</p>\n<p><strong>Indication</strong> for <strong>hysterectomy</strong> in molar pregnancy:</p>\n<ul>\n<li>Women who have completed their family</li>\n<li>Age &gt;40 years</li>\n<li><span data-preserver-spaces=\"true\">Uncontrolled hemorrhage </span></li>\n<li><span data-preserver-spaces=\"true\">Perforation during surgical evacuation.</span></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1495",
      "difficulty": "easy"
    },
    {
      "text": "A 36-year-old woman underwent suction evacuation for a hydatidiform mole. Which of the following statements is true regarding her follow-up with β-hCG estimation?",
      "choices": [
        {
          "id": 1,
          "text": "Start estimation 72 hours following evacuation"
        },
        {
          "id": 2,
          "text": "Twice weekly estimation for a month following evacuation"
        },
        {
          "id": 3,
          "text": "Monthly follow-up for 6 months after three consecutive normal values"
        },
        {
          "id": 4,
          "text": "After 6 months of follow-up, regular yearly estimation should be done"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given scenario, the patient is followed up with serum β hCG every month for 6 months.</p>\n<p><strong>Follow-up</strong> after the termination of molar pregnancy is done with <strong>serum β hCG</strong> levels. During the follow-up period, pregnancy must be avoided as it might interfere with the β hCG levels.</p>\n<p>The <strong>initial</strong> β-hCG level is obtained <strong>within 48 hours</strong> after evacuation and used as a <strong>baseline.</strong> </p>\n<p>It is measured <strong>weekly</strong> till it becomes negative, and three consecutive normal values are obtained. This normally happens in <strong>4-8 weeks. </strong></p>\n<p>After this, β hCG levels are measured <strong>monthly</strong> for <strong>6 months</strong>. Women who undergo chemotherapy must be followed up for 1 year.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1511",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following are complications that can be seen in a patient with molar pregnancy?<div class='question-desc-html'><ol>\n<li>Pre-eclampsia</li>\n<li>Hypothyroidism</li>\n<li>Breathlessness</li>\n<li>Electrolyte imbalance</li>\n<li>Uterine perforation</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, and 5"
        },
        {
          "id": 2,
          "text": "1, 2, 3 and 5"
        },
        {
          "id": 3,
          "text": "2, 3 and 4"
        },
        {
          "id": 4,
          "text": "1, 3, 4 and 5"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Thyrotoxicosis</strong> is seen as a complication of molar pregnancy, not hypothyroidism.</p>\n<p><strong>Complications</strong> in <strong>molar pregnancy</strong> include:</p>\n<ul>\n<li>Immediate:\n<ul>\n<li>Early-onset pre-eclampsia<strong>&nbsp;</strong>-&nbsp;molar placentas produce more antiangiogenic proteins than normal placentas.</li>\n<li>Thyrotoxicosis - as &alpha; component of hCG mimics TSH and causes thyroid storm</li>\n<li>Acute pulmonary insufficiency - due to embolization of trophoblastic cells</li>\n<li>Electrolyte imbalance i.e., hypokalemia, hyponatremia - due to hyperemesis caused by &beta; hCG</li>\n<li>Shock - hemorrhage due to the separation of vesicles and intra-peritoneal haemorrhage</li>\n<li>Disseminated intravascular coagulation</li>\n</ul>\n</li>\n<li>Late:&nbsp;Choriocarcinoma.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1488",
      "difficulty": "medium"
    },
    {
      "text": "Gestational trophoblastic neoplasm does not include",
      "choices": [
        {
          "id": 1,
          "text": "Partial mole"
        },
        {
          "id": 2,
          "text": "Choriocarcinoma"
        },
        {
          "id": 3,
          "text": "Placental site trophoblastic tumor"
        },
        {
          "id": 4,
          "text": "Invasive mole"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"page\" title=\"Page 1\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>A partial mole</strong> is <strong>not</strong> a gestational trophoblastic neoplasm (<strong>GTN</strong>).</p>\n<p>Gestational trophoblastic disease (<strong>GTD</strong>) is the term used to describe a group of tumors due to <strong>abnormal trophoblast proliferation</strong>. <strong>Malignant</strong> forms of GTD are termed gestational trophoblastic neoplasia (<strong>GTN</strong>).</p>\n<p>Modified WHO Classification of GTD</p>\n<table>\n<tbody>\n<tr>\n<td>Molar Pregnancies</td>\n<td>Trophoblastic tumors</td>\n</tr>\n<tr>\n<td>\n<p>Hydatidiform mole (<strong>benign</strong>) -<strong>Partial</strong> and <strong>Complete</strong><br />Invasive mole (malignant)</p>\n</td>\n<td>\n<p>Choriocarcinoma (malignant)<br />Placental site trophoblastic tumor (malignant)</p>\n<p>Epithelioid trophoblastic tumor (malignant)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7481",
      "difficulty": "easy"
    },
    {
      "text": "All of the following are non-molar trophoblastic neoplasms except _____.",
      "choices": [
        {
          "id": 1,
          "text": "Choriocarcinoma"
        },
        {
          "id": 2,
          "text": "Placental site trophoblastic tumor"
        },
        {
          "id": 3,
          "text": "Invasive mole"
        },
        {
          "id": 4,
          "text": "Epithelioid trophoblastic tumor"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Invasive mole</strong> is a <strong>molar</strong> trophoblastic neoplasm.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bdf036a480d64e4fab24ba2953602074x1280x1460.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9839",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common non-metastatic gestational trophoblastic neoplasia that develops following hydatidiform mole?",
      "choices": [
        {
          "id": 1,
          "text": "Choriocarcinoma"
        },
        {
          "id": 2,
          "text": "Placental site trophoblastic tumour"
        },
        {
          "id": 3,
          "text": "Chorioadenoma destruens"
        },
        {
          "id": 4,
          "text": "Epithelioid trophoblastic tumour"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Chorioadenoma destruens </strong>or&nbsp;<strong>i</strong><strong>nvasive mole</strong>&nbsp;is the most common <strong>non-metastatic</strong>&nbsp;<strong>GTN</strong> that follows hydatidiform moles. Almost all invasive moles arise from partial or complete moles.</p>\n<p>Invasive mole is characterized by extensive tissue invasion by trophoblast and whole villi.&nbsp;They can <strong>penetrate</strong> deep into the <strong>myometrium</strong>, peritoneum, parametrium, or vaginal vault.&nbsp;They are <strong>locally aggressive</strong> and do not usually metastasize.&nbsp;</p>\n<p>The <strong>most common GTN</strong> following term pregnancy or miscarriage is <strong>choriocarcinoma.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c4c9b153f34c4d858d5955d3df3acfd5x1280x1460.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1512",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following are risk factors for malignant change in a patient with molar pregnancy?<div class='question-desc-html'><ol>\n<li>Maternal age &gt;40 years</li>\n<li>&beta;-hCG levels &gt; 100,000 mIU/mL</li>\n<li>Theca-lutein cysts &lt; 6 cm</li>\n<li>Uterine size that is small for gestational age</li>\n<li>Grand multiparity</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 5"
        },
        {
          "id": 2,
          "text": "2, 3, 4"
        },
        {
          "id": 3,
          "text": "1, 2, 4"
        },
        {
          "id": 4,
          "text": "1, 3, 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Maternal age &gt;40 years,&nbsp;&beta;-hCG levels &gt;100,000 mIU/mL and grand multiparity are risk factors for malignant change in a patient with molar pregnancy.</p>\n<p><strong>Risk factors</strong> for <strong>malignant</strong> change are:</p>\n<ul>\n<li>Patient's age&nbsp;&ge; 40 years or &lt;20 years</li>\n<li>Parity&nbsp;&ge;3</li>\n<li>Uterine size &gt;20 weeks</li>\n<li>Previous history of molar pregnancy</li>\n<li>Complete moles have 15-20% risk of malignant transformation, partial moles have 1-5% risk</li>\n<li>Serum&nbsp;&beta; hCG &gt;1,00,000 mIU/mL</li>\n<li>Large theca lutein cysts &gt;6 cm in diameter</li>\n</ul>\n<p>Post-evacuation uterine <strong>sonographic</strong> <strong>surveillance</strong> can be used as a <strong>predictor</strong> of subsequent <strong>neoplasia</strong>.&nbsp;Findings indicative of malignant transformation are:</p>\n<ul>\n<li><strong>Suburethral nodules</strong></li>\n<li>Myometrial nodules</li>\n<li><strong>Hypervascularity.</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9845",
      "difficulty": "easy"
    },
    {
      "text": "All of the following can be indicators of choriocarcinoma except:",
      "choices": [
        {
          "id": 1,
          "text": "Increased number of theca lutein cysts"
        },
        {
          "id": 2,
          "text": "Persistently enlarged uterus"
        },
        {
          "id": 3,
          "text": "Plateau of high serum hCG"
        },
        {
          "id": 4,
          "text": "Suburethral nodule"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Increased number of theca lutein cysts is not an indicator of choriocarcinoma.<strong>&nbsp;Increased size&nbsp;</strong>or&nbsp;<strong>persistence&nbsp;</strong>of theca lutein cysts indicates <strong>choriocarcinoma</strong>.</p>\n<p>Plateau of high serum &beta;-hCG level&nbsp;for four measurements for&nbsp;&ge;3 weeks&nbsp;is an indicator of&nbsp;choriocarcinoma.</p>\n<p><strong>Risk factors</strong> for <strong>malignant</strong> change are:</p>\n<ul>\n<li>Molar pregnancy - complete moles have 15-20% risk, partial moles have 1-5% risk</li>\n<li>Patient's age&nbsp;&ge; 40 years or &lt;20 years</li>\n<li>Parity&nbsp;&ge;3</li>\n<li>Serum&nbsp;&beta; hCG &gt;1,00,000 IU/mL</li>\n<li>Uterine size &gt;20 weeks</li>\n<li>Previous history of molar pregnancy</li>\n<li>Large theca lutein cysts &gt;6 cm in diameter</li>\n</ul>\n<p>Post-evacuation uterine <strong>sonographic</strong> <strong>surveillance</strong> can be used as a <strong>predictor</strong> of subsequent <strong>neoplasia</strong>.&nbsp;Findings indicative of malignant transformation are:</p>\n<ul>\n<li><strong>Suburethral nodules</strong></li>\n<li>Myometrial nodules</li>\n<li><strong>Hypervascularity</strong>.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7142",
      "difficulty": "hard"
    },
    {
      "text": "A patient with a history of molar pregnancy was treated with suction and evacuation. Which method of contraception would you not recommend for her?",
      "choices": [
        {
          "id": 1,
          "text": "Barrier methods"
        },
        {
          "id": 2,
          "text": "Intrauterine contraceptive device"
        },
        {
          "id": 3,
          "text": "Oral contraceptive pills"
        },
        {
          "id": 4,
          "text": "Depot medroxyprogesterone acetate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>IUCD </strong>(intrauterine contraceptive device)&nbsp;is <strong>contraindicated</strong> in this patient as the <strong>uterus</strong> is <strong>friable</strong> and can cause further <strong>bleeding</strong>.&nbsp;</p>\n<p>Accepted methods of contraception after suction evacuation in molar pregnancy include:</p>\n<ul>\n<li>Oral contraceptive pills</li>\n<li>Depot medroxyprogesterone acetate</li>\n<li>Barrier methods.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9843",
      "difficulty": "medium"
    },
    {
      "text": "What will be the WHO score in a patient with low-risk gestational trophoblastic neoplasia?",
      "choices": [
        {
          "id": 1,
          "text": "0-3"
        },
        {
          "id": 2,
          "text": "0-5"
        },
        {
          "id": 3,
          "text": "0-6"
        },
        {
          "id": 4,
          "text": "0-7"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Low-risk</strong> GTN has a WHO score of <strong>0 to 6.&nbsp;</strong>High-risk GTN has a WHO score of &ge; 7.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>Low risk</strong></td>\n<td><strong>High risk</strong></td>\n</tr>\n<tr>\n<td>Total score</td>\n<td>0-6</td>\n<td>&ge;7</td>\n</tr>\n<tr>\n<td>Age</td>\n<td>&le;39 years</td>\n<td>&ge;40 years</td>\n</tr>\n<tr>\n<td>hCG</td>\n<td>&le;10<sup>5</sup> IU/L</td>\n<td>&ge;10<sup>5</sup> IU/L</td>\n</tr>\n<tr>\n<td>Type of antecedent pregnancy</td>\n<td>Molar pregnancy</td>\n<td>Full term pregnancy</td>\n</tr>\n<tr>\n<td>Duration of antecedent pregnancy</td>\n<td>&lt;4 months</td>\n<td>&gt;12 months</td>\n</tr>\n<tr>\n<td>Metastasis site</td>\n<td>Lungs, vagina</td>\n<td>Brain, liver</td>\n</tr>\n<tr>\n<td>Number of metastases</td>\n<td>&lt;4&nbsp;</td>\n<td>&gt;8</td>\n</tr>\n<tr>\n<td>Size of the tumor</td>\n<td>&lt;3 cm</td>\n<td>&gt;5 cm</td>\n</tr>\n<tr>\n<td>Antecedent chemotherapy</td>\n<td>Single-agent chemotherapy</td>\n<td>Multiple-agent chemotherapy</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1497",
      "difficulty": "medium"
    },
    {
      "text": "A patient was diagnosed to have choriocarcinoma two years post-evacuation of molar pregnancy. Which of the following is the most common site of metastasis in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Vagina"
        },
        {
          "id": 2,
          "text": "Kidney"
        },
        {
          "id": 3,
          "text": "Liver"
        },
        {
          "id": 4,
          "text": "Ovaries"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The common sites of metastases of choriocarcinoma are in the following order:</p>\n<ul>\n<li><strong>Lungs </strong>- most common</li>\n<li><strong>Vagina </strong>- second most common</li>\n<li>Vulva</li>\n<li>Kidneys</li>\n<li>Liver</li>\n<li>Ovaries</li>\n<li>Brain</li>\n<li>Bowel</li>\n</ul>\n<p>Lung metastases present as <strong>cannon-ball or snowstorm</strong> appearance on chest X-ray. Vaginal metastases present as <strong>purplish sub-urethral nodules</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1501",
      "difficulty": "medium"
    },
    {
      "text": "A case of gestational trophoblastic neoplasm is detected to have metastasis in the lungs. It is considered as stage _____.",
      "choices": [
        {
          "id": 1,
          "text": "I"
        },
        {
          "id": 2,
          "text": "II"
        },
        {
          "id": 3,
          "text": "III"
        },
        {
          "id": 4,
          "text": "IV"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Metastases in the&nbsp;<strong>lungs</strong> are considered stage <strong>III</strong>&nbsp;GTN (gestational trophoblastic neoplasia) in FIGO classification.</p>\n<p>International Federation of Gynecology and Obstetrics (FIGO) staging for GTN is as follows:</p>\n<table>\n<tbody>\n<tr>\n<td>Stage</td>\n<td>Description</td>\n</tr>\n<tr>\n<td>I</td>\n<td>GTN confined to the <strong>uterus</strong></td>\n</tr>\n<tr>\n<td>\n<p>II</p>\n</td>\n<td>\n<p>GTN extends outside of the uterus but is limited to the <strong>genital</strong> structures &nbsp;&nbsp;&nbsp;</p>\n<p>(adnexa, vagina, broad ligament)</p>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td>GTN extends to the <strong>lungs</strong>, with or without known genital tract involvement</td>\n</tr>\n<tr>\n<td>IV</td>\n<td>All <strong>other</strong> metastatic sites i.e. kidney, liver, brain, bowel, etc.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The chest X-ray below shows lung metastasis - stage III GTN.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9b4129c54c0840fb8c61afc93bbfc840x600x487.JPEG\" alt=\"Explanation Image\"><p><strong>Gestational trophoblastic neoplasia</strong> (GTN) refers to the aggressive invasion of the endometrium and myometrium by <strong>trophoblast cells</strong>. It includes <strong>invasive mole</strong>, <strong>gestational</strong> <strong>choriocarcinoma</strong>, <strong>placental site trophoblastic tumors</strong>, and<strong> epithelioid trophoblastic tumors</strong>. GTN is diagnosed based on elevated &beta;-hCG levels. FIGO criteria for diagnosis of GTN:&nbsp;</p>\n<ul>\n<li>Persistence of <strong>&beta;-hCG level plateau</strong> in <strong>4 measurements</strong> for 3 weeks or longer</li>\n<li><strong>Rise in &beta;-hCG</strong> levels in <strong>3 or more consecutiv</strong>e measurements done <strong>weekly</strong>, over a period of 2 weeks or longer</li>\n<li><strong>Elevated &beta;-hCG</strong> level for <strong>6 months</strong> or more</li>\n<li><strong>Histologic diagnosis</strong> of choriocarcinoma&nbsp;</li>\n</ul>\n<p>Treatment for <strong>low-risk disease</strong> is chemotherapy with <strong>methotrexate</strong>, while those with <strong>high-risk disease</strong> are treated with etoposide, methotrexate, and dactinomycin alternating with cyclophosphamide and vincristine (<strong>EMA/CO</strong>) chemotherapy.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a322b86670814b4e944a4e24b787e1cdx1279x2253.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9862",
      "difficulty": "medium"
    },
    {
      "text": "A 43-year-old woman presents with complaints of hemoptysis, vaginal bleeding, and abdominal pain for 7 days. Chest X-ray is shown below. Transabdominal USG revealed a solid mass occupying the uterus which was found to be choriocarcinoma with a WHO score of 8. How would you manage this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Hysterectomy"
        },
        {
          "id": 2,
          "text": "R-CHOP"
        },
        {
          "id": 3,
          "text": "EMA-CO"
        },
        {
          "id": 4,
          "text": "MVAC"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of <strong>high-risk</strong> (WHO) <strong>stage III</strong> <strong>choriocarcinoma</strong> which is treated with <strong>EMA-CO</strong> regimen. The given X-ray shows&nbsp;numerous, dense, bilateral metastatic nodules, of varying sizes indicative of lung metastases.</p>\n<p>The components of EMA-CO are:</p>\n<ul>\n<li>Etoposide</li>\n<li>Methotrexate</li>\n<li>Actinomycin D</li>\n<li>Cyclophosphamide</li>\n<li>Oncovin i.e. vincristine</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Risk</strong></td>\n<td><strong>Criteria</strong></td>\n<td><strong>Treatment</strong></td>\n</tr>\n<tr>\n<td>Low</td>\n<td>\n<ul>\n<li>FIGO stage I GTN</li>\n<li>FIGO Stage II or III GTN with a WHO risk score <span>&lt;</span>6</li>\n</ul>\n</td>\n<td>Single agent chemotherapy with Methotrextate or Actinomycin D.</td>\n</tr>\n<tr>\n<td>High</td>\n<td>\n<ul>\n<li>Stages II and III with WHO risk score <span>&gt;</span>7</li>\n<li>Stage IV disease</li>\n</ul>\n</td>\n<td>\n<p>EMA-CO regimen</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Option A: <strong>PSTT</strong> (placental-site trophoblastic tumor) and <strong>ETT</strong> (epithelioid trophoblastic tumors) are treated by <strong>hysterectomy</strong>&nbsp;only, as they are resistant to chemotherapy.</p>\n<p>Option B:&nbsp;<strong>R-CHOP</strong> regimen is used for B-cell <strong>non-Hodgkin's</strong> lymphoma.</p>\n<p>Option D:&nbsp;<strong>MVAC</strong> regimen is used for advanced <strong>bladder carcinoma</strong>.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/1fbd8e615cf646a59dafde5eb4cac3ca.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1507",
      "difficulty": "medium"
    },
    {
      "text": "Placental-site trophoblastic tumor arises from _____.",
      "choices": [
        {
          "id": 1,
          "text": "Cytotrophoblast"
        },
        {
          "id": 2,
          "text": "Syncytiotrophoblast"
        },
        {
          "id": 3,
          "text": "Intermediate trophoblast"
        },
        {
          "id": 4,
          "text": "Chorionic villi"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Placental-site trophoblastic tumor</strong> arises from implantation site <strong>intermediate trophoblast.</strong>&nbsp;As syncytiotrophoblastic cells are generally absent in this site, it is composed mainly of&nbsp;<strong>cytotrophoblastic</strong> cells.</p>\n<p>Patients with placental site trophoblastic tumors present with vaginal bleeding and modestly elevated serum &beta;-hCG levels.&nbsp;Local invasion into the myometrium and lymphatics occurs. <strong>Hysterectomy</strong> is the preferred treatment.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1508",
      "difficulty": "hard"
    },
    {
      "text": "A 26-year-old woman with a history of early miscarriage presented with amenorrhoea. Her serum beta hCG levels were persistently low and USG revealed a single solid mass in the uterine fundus. Histopathological examination of the biopsy showed abundant intermediate trophoblastic cells. What is the next step of management?",
      "choices": [
        {
          "id": 1,
          "text": "Methotrexate"
        },
        {
          "id": 2,
          "text": "Actinomycin D"
        },
        {
          "id": 3,
          "text": "EMA-CO regimen"
        },
        {
          "id": 4,
          "text": "Hysterectomy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of <strong>placental-site trophoblastic tumor</strong> (PSTT). <strong>Hysterectomy</strong> is the treatment of choice because they are locally invasive tumors and resistant to chemotherapy.</p>\n<p>PSTT is a rare tumor arising from <strong>intermediate</strong> <strong>trophoblastic</strong> of the placental bed. Patients with placental site trophoblastic tumors present with vaginal bleeding and <strong>modestly elevated</strong> serum <strong>β-hCG</strong> levels. They produce <strong>variant forms</strong> of <strong>hCG. </strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1509",
      "difficulty": "medium"
    }
  ]
}